title: Efficacy of pharmacological treatment and genetic characterization in early diagnosed patients affected by long QT syndrome with impaired AV conduction.
authors.forename: B
authors.initials: B
authors.lastname: Sarubbi
authors.forename: G
authors.initials: G
authors.lastname: Frisso
authors.forename: E
authors.initials: E
authors.lastname: Romeo
authors.forename: E
authors.initials: E
authors.lastname: Evangelista
authors.forename: A
authors.initials: A
authors.lastname: Cordella
authors.forename: M
authors.initials: M
authors.lastname: D'Alto
authors.forename: G
authors.initials: G
authors.lastname: Santarpia
authors.forename: M G
authors.initials: MG
authors.lastname: Russo
authors.forename: F
authors.initials: F
authors.lastname: Salvatore
authors.forename: R
authors.initials: R
authors.lastname: Calabrò
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D054537:Atrioventricular Block / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D042241:Early Diagnosis; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008133:Long QT Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D008297:Male; D010375:Pedigree; D016171:Torsades de Pointes / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics
chemical_list: D000889:Anti-Arrhythmia Agents